NNZ-2566, a Novel Analog of (1–3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NNZ-2566, a Novel Analog of (1–3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome
Authors
Keywords
Fragile X syndrome, Insulin growth factor 1, NNZ-2566, Behavior, Biomarkers
Journal
NEUROMOLECULAR MEDICINE
Volume 17, Issue 1, Pages 71-82
Publisher
Springer Nature
Online
2015-01-24
DOI
10.1007/s12017-015-8341-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome
- (2012) C. A. Hoeffer et al. GENES BRAIN AND BEHAVIOR
- Wild-type microglia arrest pathology in a mouse model of Rett syndrome
- (2012) Noël C. Derecki et al. NATURE
- Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice
- (2012) Aubin Michalon et al. NEURON
- Insulin-like growth factor 1 (IGF1) and its active peptide (1–3)IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms
- (2012) Aiden P. Corvin et al. NEUROSCIENCE LETTERS
- Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABAB Receptors with Arbaclofen
- (2012) C. Henderson et al. Science Translational Medicine
- AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome
- (2011) Josien Levenga et al. NEUROBIOLOGY OF DISEASE
- Dysregulation of mTOR Signaling in Fragile X Syndrome
- (2010) A. Sharma et al. JOURNAL OF NEUROSCIENCE
- Astrocytes Prevent Abnormal Neuronal Development in the Fragile X Mouse
- (2010) S. Jacobs et al. JOURNAL OF NEUROSCIENCE
- Rett Syndrome Microglia Damage Dendrites and Synapses by the Elevated Release of Glutamate
- (2010) I. Maezawa et al. JOURNAL OF NEUROSCIENCE
- IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions
- (2009) Jian Guan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Angiotensin-(1-7) through AT2receptors mediates tyrosine hydroxylase degradation via the ubiquitin-proteasome pathway
- (2009) María A. Lopez Verrilli et al. JOURNAL OF NEUROCHEMISTRY
- NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats
- (2009) Hans H Wei et al. Journal of Neuroinflammation
- NNZ-2566: A Gly–Pro–Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke
- (2009) Michael J. Bickerdike et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice
- (2009) Daniela Tropea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expanding the Mind: Insulin-Like Growth Factor I and Brain Development
- (2008) A. Joseph D'Ercole et al. ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started